Caspase activation in MCF7 cells responding to etoposide treatment

Molecular Pharmacology

Volumn 53, Issue 3, 1998, Pages 446-450

  Benjamin, Christopher W ^a   Hiebsch, Ronald R ^a   Jones, David A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN DERIVATIVE; CYSTEINE PROTEINASE; DNA; ENZYME INHIBITOR; ETOPOSIDE; FAS LIGAND; GROWTH FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0031977070     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.3.446     Document Type: Article

References (24)

1. Darmon AJ, Nicholson DW, and Bleackley RC (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature (Lond) 377:446-448.
2. Datta R, Banach D, Kojima H, Talanian RV, Alnemri ES, Wong WW, and Kufe, DW (1996) Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88:1936-1943.
3. Duke RC and Cohen JJ (1986) IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5:289-299.
4. Fernandes-Alnemri T, Litwack G, and Alnemri ES (1995) Mch-2, a new member of the apoptotic CED-3/ICE cysteine protease gene family. Cancer Res 55:2737-2742.
5. Fuchs EJ, McKenna KA, and Bedi A (1997) p53-dependent DNA Damage-Induced Apoptosis Requires FAS/APO-1-Independent Activation of CPP32-beta. Cancer Res 57:2550-2554.
6. Hain J, Weller EM, Jung T, and Burkart W (1996) Effects of ionizing- and UV B-radiation on proteins controlling cell cycle progression in human cells: comparison of the MCF7 adenocarcinoma and the SCL-2 squamous cell carcinoma cell line. Int J Rad Biol 70:261-271.
7. Idziorek T, Estaquier J, De-Bels F, and Ameisen JC (1995) YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods 185:249-258.
8. Kaufman SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cell by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49:5870-5878.
9. Kuida K, Zheng TS, Songqing N, Kuan C, Yang D, Karasuyama H, Rakic P, and Flavell RA (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (Lond) 384:368-372.
10. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
11. Lowe S (1995) Cancer therapy and p53. Curr Opin Oncol 7:547-553.
12. Margolin N, Raybuck SA, Wilson KP, Chen W, Fox T, Gu Y, and Livingston DJ (1997) Substrate and inhibitor specificity of interleukin-1â-converting enzyme and related caspases. J Biol Chem 272:7223-7228.
13. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon N, Tatar E, Tung JS, Bryant K, Takahashi A, Svingen PA, Madden BJ, McCormick DJ, Earnshaw WC, and Kaufmann SC (1997) Activation of multiple interleukin-1B converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem 272:7421-7430.
14. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Samulson ME, Yamin TT, Lu VL, and Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond) 376:37-43.
15. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K, and Takahashi T (1996) Overexpression of bax sensitizes human breast cancer MCF7 cells to radiation-induced apoptosis. Int J Cancer 67:101-105.
16. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, and Nicholson DW (1996) CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis J Biol Chem 271:1841-1844.
17. Shimizu T and Pommier Y (1997) Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia 11:1238-1244.
18. Stern M, Meagher L, Savill J, and Haslett C (1992) Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immun 148:3543-3549.
19. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, and Wong WW (1997) Substrate specificities for caspase family proteases. J Biol Chem 272:9677-9682.
20. Tewari M and Dixit VM (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270:3255-3260.
21. Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR, and Chapman KT (1994) Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methylketones. Biochemistry 33:3934-3940.
22. Ueda N and Shah SV (1994) Apoptosis. J Lab Clin Med 124:169-177.
23. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, and Salvesen GS (1997) Target protease specificity of the viral serpin CrmA. J Biol Chem 272:7797-7800.
24. Zhu H, Fearnhead HO, and Cohen GM (1995) An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP. 1 cells. FEBS Lett 374:303-308.